Lymphoma Research Foundation
MENU

DONATELEARN
LEARNDONATE


For Patients and Caregivers
About Lymphoma
Treatment Options
Resources & Support
For Healthcare Professionals
For Researchers
About LRF
About Us
Our Impact
Our Scientific Experts
Support LRF
Team LRF - Walks, Ride, DIY
Ticketed Events
Volunteer
Other Ways to Give
Subscribe
  • News
Home » Lymphoma News » Page 2
Lymphoma News

ECHELON-2 Trial Demonstrates “Practice-Changing” Results for Peripheral T-Cell Lymphomas

Lymphoma News

FDA Approves Ibrutinib (IMBRUVICA) in Combination with Obinutuzumab (GAZYVA) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Lymphoma News

U.S. Food and Drug Administration Approves Brentuximab Vedotin (ADCETRIS) for Frontline Treatment of Peripheral T-Cell Lymphoma (PTCL)

Lymphoma News

In Memoriam: Paul Allen

Lymphoma News

U.S. Food and Drug Administration Approves Duvelisib (COPIKTRA) for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma

Lymphoma News

U.S. Food and Drug Administration Approves Ibrutinib (IMBRUVICA) Plus Rituximab (RITUXAN) for Waldenström Macroglobulinemia (WM)

Lymphoma News

U.S. Food and Drug Administration Approves Mogamulizumab-kpkc (Poteligeo) for Two Most Common Types of Cutaneous T-Cell Lymphoma

Lymphoma News

U.S. Food and Drug Administration Approves Pembrolizumab (Keytruda) for Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma (PMBCL)

Lymphoma News

U.S. Food and Drug Administration Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia – With or Without 17p Deletion

Lymphoma News

U.S. Food and Drug Administration Approves Tisagenlecleucel For Relapsed/ Refractory Large B-cell Lymphoma

  • «Previous Page
  • 1
  • 2
  • 3
  • Next Page»
 

Stay informed with
news, alerts and
other resources.

   Please leave this field empty

Stay informed with
news, alerts and
other resources.

   Please leave this field empty

  • Start A Fundraiser

  • Download Our App

  • Become a Buddy

  • Attend an Event

  • Become an Advocate

  • Share Your Story

The Lymphoma Research Foundation’s mission is to eradicate lymphoma and serve those impacted by this blood cancer.

LRF Helpline: 800-500-9976|HELPLINE@LYMPHOMA.ORG

The Lymphoma Research Foundation’s mission is to eradicate lymphoma and serve those impacted by this blood cancer. LRF Helpline: 800-500-9976 HELPLINE@LYMPHOMA.ORG

CONTACT US ›|CAREERS AT LRF ›

CONTACT US ›|CAREERS AT LRF ›

Privacy Policy|Donor Privacy Policy|Gift Acceptance Policy

© 2019 Lymphoma Research Foundation

Privacy Policy|Donor Privacy Policy|Gift Acceptance Policy

© 2019 Lymphoma Research Foundation